Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2―Overexpressing Metastatic Breast CancerZHONGZHEN GUAN; BINGHE XU; LIM LEUNG, Wai et al.Journal of clinical oncology. 2013, Vol 31, Num 16, pp 1947-1953, issn 0732-183X, 7 p.Article

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab : updated efficacy and biomarker analysesCAMERON, David; CASEY, Michelle; CHAN, Arlene et al.Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 533-543, issn 0167-6806, 11 p.Article

Pooled analysis of diarrhea events in patients with cancer treated with lapatinibCROWN, John P; BURRIS, Harold A; CHAN, Steve et al.Breast cancer research and treatment. 2008, Vol 112, Num 2, pp 317-325, issn 0167-6806, 9 p.Article